Bristol-Myers Squibb Company
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
Last updated:
Abstract:
Provided herein are polypeptides which include tenth fibronectin type III domains (.sup.10Fn3) that bind to glypican-3. Also provided are fusion molecules comprising a .sup.10Fn3 domain that bind to glypican-3 for use in diagnostic and therapeutic applications. Glypican-3 .sup.10Fn3 drug conjugates are also provided.
Status:
Application
Type:
Utility
Filling date:
24 Jan 2020
Issue date:
20 Aug 2020